Earnings Feed
Start Free
Home/Insiders/Brandt Peter C.
BP
SEC Insider//CIK 0001434099

Brandt Peter C.

CIK 00014340995 companiesNEW YORK, NY
SEC Profile

Transactions

50

Companies

5

Filings

8

CIK

0001434099

Recent Transactions

50 trades
  • Award
    IN8BIO, INC.$INAB

    Stock Option (right to buy)

    2026-05-09+22,000→ 22,000 total
  • Award
    IN8BIO, INC.$INAB

    Stock Option (right to buy)

    2025-05-08+63,150→ 63,150 total
  • Exercise/Conversion
    IN8BIO, INC.$INAB

    Common Stock

    2025-04-30$0.18/sh+81,967→ 681,538 total
  • Exercise/Conversion
    IN8BIO, INC.$INAB

    Series B Warrants (right to buy)

    2025-04-30−81,967→ 0 total
  • Exercise/Conversion
    IN8BIO, INC.$INAB

    Common Stock

    2025-04-30$0.18/sh+81,967→ 599,571 total
  • Exercise/Conversion
    IN8BIO, INC.$INAB

    Series A Warrants (right to buy)

    2025-04-30−81,967→ 0 total
  • Disposition to Issuer
    IN8BIO, INC.$INAB

    Series B Warrants (right to buy)

    2025-04-27−81,967→ 0 total
  • Award
    IN8BIO, INC.$INAB

    Series A Warrants (right to buy)

    2025-04-27+81,967→ 81,967 total
  • Award
    IN8BIO, INC.$INAB

    Series B Warrants (right to buy)

    2025-04-27+81,967→ 81,967 total
  • Disposition to Issuer
    IN8BIO, INC.$INAB

    Series A Warrants (right to buy)

    2025-04-27−81,967→ 0 total
  • Award
    IN8BIO, INC.$INAB

    Stock Option (right to buy)

    2024-12-19+49,490→ 49,490 total
  • Disposition to Issuer
    IN8BIO, INC.$INAB

    Series A Warrants (right to buy)

    2024-10-04−81,967→ 0 total
  • Award
    IN8BIO, INC.$INAB

    Series A Warrants (right to buy)

    2024-10-04+81,967→ 81,967 total
  • Award
    IN8BIO, INC.$INAB

    Series C Warrants (right to buy)

    2024-10-04+253,164→ 253,164 total
  • Award
    IN8BIO, INC.$INAB

    Common Stock

    2024-10-04+253,164→ 517,604 total
  • Award
    IN8BIO, INC.$INAB

    Stock Option (right to buy)

    2024-06-12+33,650→ 33,650 total
  • Award
    IN8BIO, INC.$INAB

    Series A Warrants (right to buy)

    2023-12-13+81,967→ 81,967 total
  • Award
    IN8BIO, INC.$INAB

    Common Stock

    2023-12-13+81,967→ 264,440 total
  • Award
    IN8BIO, INC.$INAB

    Series B Warrants (right to buy)

    2023-12-13+81,967→ 81,967 total
  • Award
    IN8BIO, INC.$INAB

    Stock Option (right to buy)

    2023-06-15+85,000→ 85,000 total
  • Purchase
    IN8BIO, INC.$INAB

    Common Stock

    2022-08-16$1.90/sh+105,263→ 182,473 total
  • Award
    IN8BIO, INC.$INAB

    Stock Option (right to buy)

    2022-06-01+10,500→ 10,500 total
  • Award
    IN8BIO, INC.$INAB

    Stock Option (right to buy)

    2022-06-01+13,500→ 13,500 total
  • Award
    IN8BIO, INC.$INAB

    Stock Option (right to buy)

    2021-07-29+10,500→ 10,500 total
  • Award
    Opus Genetics, Inc.$IRD

    Stock Option (right to buy)

    2019-06-06+3,537→ 3,537 total
  • Award
    Opus Genetics, Inc.$IRD

    Stock Option (right to buy)

    2018-06-28+39,742→ 39,742 total
  • Award
    Opus Genetics, Inc.$IRD

    Stock Option (right to buy)

    2017-04-11+110,000→ 110,000 total
  • Award
    Opus Genetics, Inc.$IRD

    Stock Option (right to buy)

    2016-06-09+225,000→ 225,000 total
  • Award
    Opus Genetics, Inc.$IRD

    Stock Option (right to buy)

    2015-09-16+90,000→ 90,000 total
  • Other
    AUXILIUM PHARMACEUTICALS INC

    Nonqualified Stock Option (Right to Buy)

    2015-01-29$36.53/sh−15,000→ 0 total
  • Other
    AUXILIUM PHARMACEUTICALS INC

    Common Stock

    2015-01-29−20,000→ 5,000 total
  • Other
    AUXILIUM PHARMACEUTICALS INC

    Common Stock

    2015-01-29$36.53/sh−5,000→ 0 total
  • Other
    AUXILIUM PHARMACEUTICALS INC

    Nonqualified Stock Option (Right to Buy)

    2015-01-29$36.53/sh−5,000→ 0 total
  • Other
    AUXILIUM PHARMACEUTICALS INC

    Nonqualified Stock Option (Right to Buy)

    2015-01-29$36.53/sh−5,000→ 0 total
  • Other
    AUXILIUM PHARMACEUTICALS INC

    Nonqualified Stock Option (Right to Buy)

    2015-01-29$36.53/sh−5,000→ 0 total
  • Other
    AUXILIUM PHARMACEUTICALS INC

    Nonqualified Stock Option (Right to Buy)

    2015-01-29$36.53/sh−15,000→ 0 total
  • Award
    Opus Genetics, Inc.$IRD

    Stock Options (right-to-buy)

    2013-06-11+60,000→ 60,000 total
  • Award
    AUXILIUM PHARMACEUTICALS INC

    Nonqualified Stock Option (Right to Buy)

    2013-05-01+5,000→ 5,000 total
  • Award
    AUXILIUM PHARMACEUTICALS INC

    Common Stock

    2013-05-01+5,000→ 20,000 total
  • Disposition to Issuer
    EPOCRATES INC

    Common Stock

    2013-03-12−38,729→ 0 total
  • Disposition to Issuer
    EPOCRATES INC

    Non-Qualified Stock Option (right to buy)

    2013-03-12−19,650→ 0 total
  • Disposition to Issuer
    EPOCRATES INC

    Non-Qualified Stock Option (right to buy)

    2013-03-12−100,000→ 0 total
  • Disposition to Issuer
    EPOCRATES INC

    Non-Qualified Stock Option (right to buy)

    2013-03-12−11,790→ 0 total
  • Disposition to Issuer
    EPOCRATES INC

    Non-Qualified Stock Option (right to buy)

    2013-03-12−11,790→ 0 total
  • Award
    EPOCRATES INC

    Non-Qualified Stock Option (right to buy)

    2012-08-13+11,790→ 11,790 total
  • Award
    AUXILIUM PHARMACEUTICALS INC

    Common Stock

    2012-06-21+5,000→ 15,000 total
  • Award
    AUXILIUM PHARMACEUTICALS INC

    Nonqualified Stock Option (Right to Buy)

    2012-06-21+5,000→ 5,000 total
  • Award
    Opus Genetics, Inc.$IRD

    Stock Options (right-to-buy)

    2012-06-18+20,000→ 20,000 total
  • Purchase
    AUXILIUM PHARMACEUTICALS INC

    Common Stock

    2012-02-28$20.09/sh+300→ 300 total
  • Purchase
    AUXILIUM PHARMACEUTICALS INC

    Common Stock

    2012-02-28$20.10/sh+9,700→ 10,000 total

Companies

5

Recent Filings

8

Address

C/O IN8BIO, INC. 350 5TH AVE. SUITE 5330

NEW YORK, NY, 10118

View on SEC.gov